REGULATORY WATCH BRIEFHigh 74📜 Final Regulationin effect
FDA classifies digital cervical cytology slide imaging system with AI as Class II device
The classification creates a regulatory framework for AI‑enabled medical devices, affecting developers, manufacturers, and patients.
ADTP Regulatory Watch· November 5, 2026· Food and Drug Administration
ImpactHigh 74
Type📜 Final Regulation
Statusin effectin force
JurisdictionUS
Effective5 November 2026
What happened
The Food and Drug Administration is classifying the digital cervical cytology slide imaging system with an artificial intelligence algorithm into Class II with special controls. The rule is effective on 2026-11-05. The agency says the classification provides reasonable assurance of safety and effectiveness while reducing regulatory burdens.
Why it matters for trust and compliance
Its status is in effect. It is in force now.
The classification creates a regulatory framework for AI‑enabled medical devices, affecting developers, manufacturers, and patients.
Takes effect November 5, 2026.
Who is affected
healthcaretechnologymanufacturerdeveloperdeployer
Recommended actions
Inventory AI or automated decision systems in scope and their assessments.
Confirm handling of sensitive data categories meets the stricter rules.
Regulations library
Every US state privacy law, on one map
24 states have a comprehensive privacy law in the library, alongside the EU, UK, US federal and global laws: 102 in all, each explained in plain words with its sources. Select a state to see what applies there.